首页> 外国专利> CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER, ATHEROSCLEROSIS, DIABETES AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES

CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER, ATHEROSCLEROSIS, DIABETES AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES

机译:CMI序列作为未来癌症,动脉粥样硬化,糖尿病和CNS的疾病以及治疗和预防这些疾病的目标的早期标记

摘要

Described are CMI (Cow Milk Isolate) nucleotide sequences as well as probes and primers comprising part of said nucleotide sequences and antibodies against polypeptides encoded by said nucleotide sequences. Said compounds are useful as early markers for the future development of cancer, diabetes, atherosclerosis and diseases of the CNS (Multiple sclerosis MS, Prion-linked diseases, amyotrophic lateral sclerosis, transmissible spongiforme encephalitis, Parkinson's disease, Alzheimer disease) and should represent targets for treatment and prevention.
机译:描述的是CMI(牛奶分离)核苷酸序列以及包含由所述核苷酸序列编码的多肽的一部分所述核苷酸序列和抗体的探针和引物。 所述化合物可用作未来癌症,糖尿病,动脉粥样硬化和疾病的早期标记(多发性硬化症MS,朊病毒联系疾病,肌萎缩疾病,传染性海绵状脑炎,帕金森病,阿尔茨海默病),并应代表目标 用于治疗和预防。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号